ARGX Dec 2024 460.000 call
| Previous close | 36.40 |
| Open | 36.00 |
| Bid | 16.70 |
| Ask | 21.50 |
| Strike | 460.00 |
| Expiry date | 2024-12-20 |
| Day's range | 36.00 - 36.40 |
| Contract range | N/A |
| Volume | |
| Open interest | 13 |
GlobeNewswireargenx to Present at Goldman Sachs 45th Annual Global Healthcare Conference
June 4, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of management will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11, 2024 at 2:40 PM ET in Miami, FL. A live webcast of the fireside chat may be accessed on the Investors section of the argenx website at argenx.com/inv
Investor's Business DailyAfter Biohaven Kerfuffle, Immunovant Dives On A Surprise Delay
Immunovant stock slumped Thursday — reversing a day-earlier jump — after pivoting its focus to what one analyst called "a backup compound."
Investor's Business DailyBiohaven Tumbles After Protein-Degrading Drug Misses Expectations; Immunovant, Argenx Jump
Biohaven stock tumbled Wednesday after the company's experimental protein-degrading drug lagged investor expectations.
